Abstract
Background
According to the European Drug Report, the use of novel psychoactive substances (NPS) is constantly growing. NPS are widely abused by human adolescent subjects. 5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is one of the most frequently used hallucinogenic NPS. 5-MeO-DIPT intoxication results in hallucinations, vomiting, and tachycardia. Long-term exposure to 5-MeO-DIPT was reported to lead to development of post-hallucinogenic perception disorder.
The aim of the present study was to determine whether repeated-intermittent administration of 5-MeO-DIPT during adolescence affects learning and memory in adult rats.
Methods
Rats were treated with 5-MeO-DIPT in a dose of 2.5 mg/kg from 30 to 33 and 37 to 40 Postnatal Day (PND). The experiments were conducted when the animals reached 90 PND. The effect of 5-MeO-DIPT on cognitive functions was assessed using the novel object recognition, open field, and serial pattern learning (SPL) tests.
Results
Repeated-intermittent exposure to 5-MeO-DIPT during adolescence decreased the number of crossings in the open field test at adulthood. Moreover, 5-MeO-DIPT treatment impaired adult rats’ learning in the SPL test. There was no change in the novel object recognition test.
Conclusions
The present results show that the performance of adult rats treated with 5-MeO-DIPT during adolescence was impaired in the open field test, which indicates the attenuated exploratory activity. 5-MeO-DIPT treatment undermined adult rats’ performance in the serial pattern learning test, suggesting impairment of long term memory and cognitive flexibility. The present study showed that the exposure to 5-MeO-DIPT during adolescence might lead to long-lasting behavioral changes which persisted long after the exposure period.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
European Monitoring Centre of Drugs and Drug Addiction. European Drug Report 2017: Trends and Developments 2017. https://doi.org/www.emcdda.europa.eu/edr2017_en. (Accessed 18 August 2017).
Tracy D.K., Wood DM, Baumeister D. Novel psychoactive substances: types, mechanisms of action, and effects. BMJ 2017;356:i6848, doi:https://doi.org/10.1136/bmj.i6848.
Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res 2015;15(277):99–120, doi:https://doi.org/10.1016/j.bbr.2014.07.016.
Drug Enforcement Administration. 5-methoxy-N, N-diisopropyttryptamine (Street Names: Foxy, or Foxy methoxy) 2013. https://doi.org/www.deadiversion.usdoj.gov/drug_chem_info/5meodipt.pdf. (Accessed 28 February 2016).
Górska AM, Noworyta-Sokołowska K, Gołembiowska K. The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum. Pharmacol Rep 2014;66(4):718–21, doi:https://doi.org/10.1016/j.pharep.2014.03.003.
Tittarelli R, Mannocchi G, Pantano F, Romolo FS. Recreational use, analysis and toxicity of tryptamines. Curr Neuropharmacol 2015;13(1):26–46, doi:https://doi.org/10.2174/1570159x13666141210222409.
Ikeda A, Sekiguchi K, Fujita K, Yamadera H, Koga Y. 5-Methoxy-N, N-Diisopropyltryptamine-induced flashbacks. Am J Psychiatry 2005;162(4):815, doi:https://doi.org/10.1176/appi.ajp.162.4.815.
Fuse-Nagase Y, Nishikawa T. Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser. Addict Sci Clin Pract 2013;8(1):1–3, doi:https://doi.org/10.1186/1940-0640-8-9.
Nagai F, Nonaka R, Satoh Hisashi Kamimura K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 2007;559(2–3):132–7, doi:https://doi.org/10.1016/j.ejphar.2006.11.075.
Sogawa C, Sogawa N, Tagawa J, Fujino A, Ohyama K, Asanuma M, et al. 5-Methoxy-N, N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. Toxicol Lett 2007;170(1):75–82, doi:https://doi.org/10.1016/j.toxlet.2007.02.007.
Noworyta-Sokołowska K, Kamińska K, Kreiner G, Rogóż Z, Gołembiowska K. Neurotoxic effects of 5-MeO-DIPT: a psychoactive tryptamine derivative in rats. Neurotox Res 2016;30(4):606–19, doi:https://doi.org/10.1007/s12640-016-9654-0.
Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, et al. Hallucinogen-like actions of 5-methoxy-N, N-diisopropyltryptamine in mice and rats. Pharmacol Biochem Behav 2006;83(1):122–9, doi:https://doi.org/10.1016/j.pbb.2005.12.015.
Williams MT, Herring NR, Schaefer TL, Skelton MR, Campbell NG, Lipton JW, et al. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine (Foxy) to adult rats: a new drug of abuse. Neuropsychopharmacology 2006;32(1):1404–20, doi:https://doi.org/10.1038/sj.npp.1301232.
Izenwasser S. Differential effects of psychoactive drugs in adolescents and adults. Crit Rev Neurobiol 2005;17(2):51–67.
Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000;24(4):417–63.
Squeglia LM, Jacobus J, Tapert SF. The influence of substance use on adolescent brain development. Clin EEG Neurosci Off J EEG Clin Neurosci Soc ENCS 2009;40(1):31–8.
Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 1988;31:47–59.
Orzelska-Gorka J, Talarek S, Listos J, Kedzierska E, Fidecka S. l-NAME differential effects on diazepam and flunitrazepam responses of rats in the object recognition test. Pharmacol Rep 2016;68(4):728–32, doi:https://doi.org/10.1016/j.pharep.2016.03.012.
Hall C, Ballachey EL. A study of the rat’s behavior in a field: a contribution to method in comparative psychology. Univ Calif Publ Psychol 1932;6:1–12.
Nikiforuk A, Kos T, Fijał K, Hołuj M, Rafa D, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS One 2013;8(6):e66695, doi:https://doi.org/10.1371/journal.pone.0066695.
Self R, Gaffan EA. An analysis of serial pattern learning by rats. Anim Learn Behav 1983;11(1):10–8, doi:https://doi.org/10.3758/BF03212301.
Compton DM, Selinger MC, Westman E, Otero P. Modification of serial pattern learning by designer tryptamine exposure during adolescence: comparison with damage to the dorsal hippocampus or prefrontal cortex. Int J Psychol Behav Sci 2012;2(6):263–73, doi:https://doi.org/10.5923/j.ijpbs.20120206.10.
Hulse SH, Dorsky NP. Serial pattern learning by rats: transfer of a formally defined stimulus relationship and the significance of nonreinforcement. Anim Learn Behav 1979;7(2):211–20, doi:https://doi.org/10.3758/BF03209273.
Compton DM, Dietrich KL, Selinger MC, Testa EK. 5-methoxy-N, N-di(iso) propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence. Physiol Behav 2011;103(2):203–9, doi:https://doi.org/10.1016/j.physbeh.2011.01.021.
Compton DM, Selinger MC, Westman E, Otero P. Differentiation of MDMA or 5-MeO-DIPT induced cognitive deficits in rat following adolescent exposure. Psychol Neurosci 2011;4(1):157–69, doi:https://doi.org/10.3922/j.psns.2011.1.018.
Skelton MR, Schaefer TL, Herring NR, Grace CE, Vorhees CV, Williams MT. Comparison of the developmental effects of 5-methoxy-N, N-diisopropyltryptamine (Foxy) to (±)-3, 4-methylenedioxymethamphetamine (ecstasy) in rats. Psychopharmacology (Berl) 2009;204(2):287–97, doi:https://doi.org/10.1007/s00213-009-1459-x.
Walsh RN, Cummins RA. The open-field test: a critical review. Psychol Bull 1976;83(3):482–504.
Cunha MP, Pazini FL, Oliveira Á, Machado DG, Rodrigues ALS. Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice. Brain Res Bull 2013;95:61–9, doi:https://doi.org/10.1016/j.brainresbull.2013.01.005.
Nichols DE. Psychedelics. Pharmacol Rev 2016;68(2):264–355, doi:https://doi.org/10.1124/pr.115.011478.
Dalley JW, Cardinal RN, Robbins TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004;28(7):771–84, doi:https://doi.org/10.1016/j.neubiorev.2004.09.006.
Borg J, Henningsson S, Saijo T, Inoue M, Bah J, Westberg L, et al. Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. Int J Neuropsychopharmacol 2009;12(6):783–92, doi:https://doi.org/10.1017/S1461145708009759.
Falkenberg LE, Westerhausen R, Craven AR, Johnsen E, Kroken RA, Løberg E-M, et al. Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia. NeuroImage Clin 2014;4:576–84, doi:https://doi.org/10.1016/j.nicl.2014.03.014.
Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, et al. Neurotransmitter receptors and cognitive dysfunction in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol 2012;97(1):1–13, doi:https://doi.org/10.1016/j.pneurobio.2012.02.002.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Noworyta-Sokołowska, K., Górska, A.M. & Gołembiowska, K. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats. Pharmacol. Rep 70, 890–895 (2018). https://doi.org/10.1016/j.pharep.2018.04.001
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2018.04.001